Prostate Cancer
GU Cancers Symposium 2013 - ARN-509 in men with high-risk non-metastatic castration-resistant prostate cancer, by Matthew R. Smith, MD, PhD - Session Highlights
February 19, 2013
Elderly prostate cancer patients: Patient information and shared decision making - Abstract
February 19, 2013
Fracture after androgen deprivation therapy among men with a high baseline risk of skeletal complications - Abstract
February 19, 2013
Hybrid registration of prostate and seminal vesicles for image guided radiation therapy - Abstract
February 19, 2013
Estimation of a self-consistent set of radiobiological parameters from hypofractionated versus standard radiation therapy of prostate cancer - Abstract
February 19, 2013
Patient-health care provider communication among patients with newly diagnosed prostate cancer: Findings from a population-based survey - Abstract
February 19, 2013
Place of residence and primary treatment of prostate cancer: Examining trends in rural and nonrural areas in Wisconsin - Abstract
February 19, 2013
Understanding and implementing immunotherapy for prostate cancer, by Charles G. Drake, MD, PhD of Johns Hopkins Kimmel Cancer Center
February 19, 2013
Agents that target androgen synthesis in castration-resistant prostate cancer - Abstract
February 19, 2013
Value of real-time elastography to guide the systematic prostate biopsy in men with normal digital rectal exam - Abstract
February 19, 2013